tiprankstipranks
Rallybio price target lowered to $13 from $14 at Wedbush
PremiumThe FlyRallybio price target lowered to $13 from $14 at Wedbush
3M ago
Rallybio price target lowered to $8 from $16 at JMP Securities
PremiumThe Fly
Rallybio price target lowered to $8 from $16 at JMP Securities
3M ago
Rallybio price target lowered to $12 from $17 at H.C. Wainwright
PremiumThe Fly
Rallybio price target lowered to $12 from $17 at H.C. Wainwright
3M ago
Rallybio price target lowered to $15 from $18 at Evercore ISI
PremiumThe FlyRallybio price target lowered to $15 from $18 at Evercore ISI
4M ago
Rallybio announces data for RLYB11, extends runway to Q325
PremiumThe Fly
Rallybio announces data for RLYB11, extends runway to Q325
4M ago
Rallybio announces preliminary data from multiple dose cohort of RLYB212 trial
PremiumThe Fly
Rallybio announces preliminary data from multiple dose cohort of RLYB212 trial
5M ago
Rallybio participates in a conference call with JPMorgan
PremiumThe FlyRallybio participates in a conference call with JPMorgan
8M ago
Rallybio presents Phase 1 single ascending dose data for RLYB116
PremiumThe Fly
Rallybio presents Phase 1 single ascending dose data for RLYB116
8M ago
Rallybio reports Q2 EPS (46c), consensus (48c)
PremiumThe Fly
Rallybio reports Q2 EPS (46c), consensus (48c)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100